Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence
Crossref DOI link: https://doi.org/10.1038/npp.2017.205
Published Online: 2017-08-31
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reed, Brian
Butelman, Eduardo R
Fry, Rebecca S
Kimani, Rachel
Kreek, Mary Jeanne
Text and Data Mining valid from 2017-08-31
Version of Record valid from 2017-08-31
Article History
Received: 26 May 2017
Revised: 14 August 2017
Accepted: 27 August 2017
First Online: 31 August 2017